Immunohistochemistry (IHC), western blots, and RT-qPCR were used to detect the expression of METTL3 in PC, and the results showed that METTL3 protein and mRNA levels were significantly higher in tumor samples than in paracancer samples. This evidence concerns the gene METTL3 and pachyonychia congenita.